24 studies found for:    Progressive Multifocal Leukoencephalopathy
Show Display Options
Rank Status Study
21 Completed Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort
Conditions: Multiple Sclerosis;   Relapse
Intervention:
22 Completed Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control
Condition: Multiple Sclerosis
Intervention:
23 Enrolling by invitation John Cunningham Virus (JCV) Antibody Study of Multiple Sclerosis (MS) Patients With Relapsing Forms of MS Receiving Treatment With Tysabri
Condition: Multiple Sclerosis
Intervention: Drug: Tysabri
24 Active, not recruiting Drug Exposure Registry for GSK2248761, an Investigational NNRTI
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK2248761

Show previous page of results Previous Page (1-20) Studies Shown (21-24) Next Page
Indicates status has not been verified in more than two years